Skip to main content
Fig. 9 | Journal of Nanobiotechnology

Fig. 9

From: Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Fig. 9

(A) The hemolysis of HMMDN-Met@PM of different concentrations (Negative control, normal saline; positive control, DI water). (B, C) blood biochemical, blood routine analysis before (0 d) and post-injection of HMMDN-Met@PM at 1, 7, 21 d. (D) H&E staining of separated organs including the heart, liver, spleen, lungs, kidneys of healthy mice without treatment (Control) and after injected with HMMDN-Met@PM for 1, 7 and 21 d (scale bar: 50 μm)

Back to article page